Surface-modified Epirubicin-HCl liposomes and its in vitro assessment in breast cancer cell-line: MCF-7

References

• Allen TM, Hansen C, Martin F, et al. (1991). Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1066:29–36
   PubMed Web of Science ®Google Scholar
• Ellman GL. (1959). Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–7
   PubMed Web of Science ®Google Scholar
• Gatter KC, Brown G, Trowbridge IS, et al. (1983). Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol 36:539–45
   PubMed Web of Science ®Google Scholar
• Gewirtz DA. (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57:727–41
   PubMed Web of Science ®Google Scholar
• Gianni L, Norton L, Wolmark N, et al. (2009). Role of anthracyclines in the treatment of early breast cancer. J Clin Oncol 27:4798–808
   PubMed Web of Science ®Google Scholar
• Gijsens A, Derycke A, Missiaen L, et al. (2002). Targeting of the photocytotoxic compound AlPcS4 to Hela cells by transferrin conjugated PEG-liposomes. Int J Cancer 101:78–85
   PubMed Web of Science ®Google Scholar
• Habashy HO, Powe DG, Staka CM, et al. (2010). Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Res Treat 119:283–93
   PubMed Web of Science ®Google Scholar
• Harvie P, Wong FM, Bally MB. (2000). Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles. J Pharm Sci 89:652–63
   PubMed Web of Science ®Google Scholar
• Henderson IC. (1991). Chemotherapy for metastatic disease. In: Harris JR, Hellman S, Henderson IC, eds. Breast diseases. 2nd ed. Philadelphia (PA): Lippincott, 604–65
   Google Scholar
• ICH Guideline Q1A(R2). (2003). Guidance for industry – stability testing of new drug substances and products. Geneva: ICH
   Google Scholar
• Jinturkar KA, Anish C, Kumar MK, et al. (2012). Liposomal formulations of Etoposide and Docetaxel for p53 mediated enhanced cytotoxicity in lung cancer cell lines. Biomaterials 33:2492–507
   PubMed Web of Science ®Google Scholar
• Khatri N, Rathi M, Baradia D, Misra A. (2014). cRGD Grafted siRNA nano-constructs for chemosensitization of gemcitabine hydrochloride in lung cancer treatment. Pharm Res. Early online: 1–13. doi: 10.1007/s11095-014-1351-1
   Web of Science ®Google Scholar
• Kolate A, Baradia D, Patil S, et al. (2014). PEG – a versatile conjugating ligand for drugs and drug delivery systems. J Control Release 192C:67–81
   Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–75
   PubMed Web of Science ®Google Scholar
• Maeda H, Sawa T, Konno T. (2001). Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 74:47–61
   PubMed Web of Science ®Google Scholar
• OECD Guideline for Testing of Chemicals. (2008). OECD Test Guideline 420: acute oral toxicity-fixed dose procedure: OECD Publishing, Organization for Economic Co-operation and Development. Paris, France: OECD
   Google Scholar
• Rathod S, Deshpande SG. (2010). Design and evaluation of liposomal formulation of pilocarpine nitrate. Indian J Pharm Sci 72:155–60
   PubMed Web of Science ®Google Scholar
• Risbud M, Saheb DN, Jog J, Bhonde R. (2001). Preparation, characterization and in vitro biocompatibility evaluation of poly(butylene terephthalate)/wollastonite composites. Biomaterials 22:1591–7
   PubMed Web of Science ®Google Scholar
• Ryberg M, Nielsen D, Cortese G, et al. (2008). New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients. J Natl Cancer Inst 100:1058–67
   PubMed Web of Science ®Google Scholar
• Saffari M, Shirazi HF, Oghabian MA, Moghimi HR. (2013). Preparation and in-vitro evaluation of an antisense-containing cationic liposome against non-small cell lung cancer: a comparative preparation study. Iran J Pharm Res 12:3–10
   PubMedGoogle Scholar
• Sambrook J, Russell DW. (2006). SDS-polyacrylamide gel electrophoresis of proteins. CSH Protoc 2006 (4). pii: pdb.prot4540. doi: 10.1101/pdb.prot4540
   Google Scholar
• Shan K, Lincoff AM, Young JB. (1996). Anthracycline-induced cardiotoxicity. Ann Intern Med 125:47–58
   PubMed Web of Science ®Google Scholar
• Subramanian N, Murthy RS. (2004). Use of electrolyte induced flocculation technique for an in vitro steric stability study of steric stabilized liposome formulations. Pharmazie 59:74–6
   PubMed Web of Science ®Google Scholar
• Tari A, Huang L. (1989). Structure and function relationship of phosphatidylglycerol in the stabilization of phosphatidylethanolamine bilayer. Biochemistry 28:7708–12
   PubMed Web of Science ®Google Scholar
• Tonik SE, Shindelman JE, Sussman HH. (1986). Transferrin receptor is inversely correlated with estrogen receptor in breast cancer. Breast Cancer Res Treat 7:71–6
   PubMed Web of Science ®Google Scholar
• Torchilin V. (2011). Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 63:131–5
   PubMed Web of Science ®Google Scholar
• Van Der Heijden M, Ackland SP, Deveridge S. (1998). Haemolytic uraemic syndrome associated with bleomycin, epirubicin and cisplatin chemotherapy – a case report and review of the literature. Acta Oncol 37:107–9
   PubMed Web of Science ®Google Scholar
• Walker RA, Day SJ. (1986). Transferrin receptor expression in non-malignant and malignant human breast tissue. J Pathol 148:217–24
   PubMed Web of Science ®Google Scholar
• Wang W, Xiong W, Zhu Y, et al. (2010). Protective effect of PEGylation against poly(amidoamine) dendrimer-induced hemolysis of human red blood cells. J Biomed Mater Res B Appl Biomater 93:59–64
   PubMed Web of Science ®Google Scholar
• Winer EP, Morrow M, Osborne CK. (2001). Malignant tumors of the breast. In: Devita VT, Hellman S, Rosenberg RA, eds. Cancer: principles and practice of oncology. Philadelphia, PA: Lippincott Williams & Wilkins, 1651–717
   Google Scholar
• Yuan F, Dellian M, Fukumura D, et al. (1995). Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55:3752–6
   PubMed Web of Science ®Google Scholar